NCT04422977

Brief Summary

A seroconversion test for SARS-Cov-2 will be offered to all the employees of a care institution, which has treated 240 patients hospitalized for COVID disease between 28/02 and 30/04/2020. The seroconversion test will be with a questionnaire to determine:

  • whether the subject has shown signs of infection in the last 3 recent months
  • if the subject has been in contact with COVID-diagnosed subjects (RT-PCR diagnosis or scanner) outside of the activity or within the professional activity (patient or colleague)
  • Working conditions during the period
  • The level of knowledge and respect of the barrier measures practices.
  • Respect for distance during meals professional. Overall seroprevalence and stratified seroprevalence by care and administrative areas will be determined.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
957

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2020

Completed
3 days until next milestone

Study Start

First participant enrolled

June 8, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2020

Completed
Last Updated

April 4, 2024

Status Verified

April 1, 2024

Enrollment Period

1 month

First QC Date

June 5, 2020

Last Update Submit

April 3, 2024

Conditions

Sars-CoV2

Outcome Measures

Primary Outcomes (1)

  • Measurement of overall seroprevalence of SARS-Cov-2 in an hospital staff with a seroconversion test for SARS-Cov-2

    Measurement of overall seroprevalence of SARS-Cov-2 in an hospital staff

    1 month

Study Arms (1)

CoVID exposure

OTHER
Diagnostic Test: Sars-Cov-2 serology

Interventions

Sars-Cov-2 serologyDIAGNOSTIC_TEST

Measurement of overall seroprevalence of SARS-Cov-2 in an hospital staff

Also known as: serology
CoVID exposure

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject who worked at Saint Joseph Saint Luke's Hospital during the epidemic wave (male or female).
  • Free and informed consent
  • Social security affiliation

You may not qualify if:

  • Subject refusal
  • Subject on leave during the entire period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier St Joseph St Luc

Lyon, 69007, France

Location

Related Publications (1)

  • Vivier E, Pariset C, Rio S, Armand S, Doroszewski F, Richard D, Chardon M, Romero G, Metral P, Pecquet M, Didelot A. Specific exposure of ICU staff to SARS-CoV-2 seropositivity: a wide seroprevalence study in a French city-center hospital. Ann Intensive Care. 2021 May 13;11(1):75. doi: 10.1186/s13613-021-00868-8.

    PMID: 33987718DERIVED

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2020

First Posted

June 9, 2020

Study Start

June 8, 2020

Primary Completion

July 10, 2020

Study Completion

July 10, 2020

Last Updated

April 4, 2024

Record last verified: 2024-04

Locations

FR(1)